Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

エトミダート,鎮静剤,神経内分泌の変化

P Preziosi

    Lancet (London, England)
    |July 30, 1983
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Chromaffin cells: the peripheral brain.

    Molecular psychiatry·2012
    Same author

    In vitro testing for lung toxicity.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Neurotransmitters of the non-adrenergic non-cholinergic relaxation of proximal stomach.

    European review for medical and pharmacological sciences·2008
    Same author

    Treatment of lacrimal stenoses obstructions with interventional radiology: immediate and 5-year follow-up results.

    La Radiologia medica·2008
    Same author

    Self-reported skin sensitivity in a general adult population in France: data of the SU.VI.MAX cohort.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2006
    Same author

    [Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis].

    La Revue de medecine interne·2006
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る